Back
Viking Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Buy
73
VKTX
Viking Therapeutics
Last Price:
79.91
Seasonality Move:
16.43%
Buy
70
LLY
Eli Lilly and
Last Price:
774.92
Seasonality Move:
2.06%
Buy
73
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $79.59. The Score for VKTX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $777.77. The Score for LLY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $79.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $777.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.5 | Buy |
Relative Strength Index (14 RSI): | 62.78 | Buy |
Chaikin Money Flow: | 535286 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.6 - 77.14) | Buy |
Bollinger Bands (100): | (23 - 74.9) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.62 | Buy |
Relative Strength Index (14 RSI): | 56.93 | Buy |
Chaikin Money Flow: | 2400478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (736.17 - 772.19) | Buy |
Bollinger Bands (100): | (634.73 - 779.71) | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.03 | Buy |
20-day SMA: | 70.98 | Buy |
50-day SMA: | 73.94 | Buy |
200-day SMA: | 30.88 | Buy |
8-day EMA: | 76.2 | Buy |
20-day EMA: | 73.32 | Buy |
50-day EMA: | 66.67 | Buy |
200-day EMA: | 39.69 | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 757.99 | Buy |
20-day SMA: | 749.59 | Buy |
50-day SMA: | 760.9 | Buy |
200-day SMA: | 633.45 | Buy |
8-day EMA: | 758.92 | Buy |
20-day EMA: | 754.81 | Buy |
50-day EMA: | 746.17 | Buy |
200-day EMA: | 641.26 | Buy |
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.41 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.91 per share, a decrease next quarter of $0.30 per share, an increase this year of $7.35 per share, and an increase next year of $5.03 per share.
Viking Therapeutics Technical Analysis
Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |